Aspiriant LLC’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$223K Buy
744
+15
+2% +$4.71K 0.01% 386
2026
Q2
$206K Buy
+729
New +$210K 0.01% 384
2026
Q1
– Sell
-603
Closed -$204K – 341
2025
Q4
$204K Buy
+603
New +$206K 0.01% 315
2024
Q2
– Sell
-1,088
Closed -$264K – 294
2024
Q1
$264K Hold
1,088
– – 0.01% 272
2023
Q4
$223K Buy
+1,088
New +$212K 0.01% 278

Other funds holding COR

Aspiriant LLC's COR Position: Q3 2026 in Review

Aspiriant LLC increased its Cencora (COR) stake by 2.1% in Q3 2026, buying an estimated $4.71K and bringing the position to 744 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #386.

Aspiriant LLC first reported a position in COR in Q4 2023 and has held it in 5 quarters since. The position peaked at $264K in Q1 2024. 317 funds tracked by Wall St. Rank hold COR as of Q3 2026.

  • Aspiriant LLC held 744 shares of Cencora worth $223K as of Q3 2026.
  • Aspiriant LLC bought 15 Cencora shares in Q3 2026, an estimated $4.71K.
  • Cencora made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #386 holding.
  • Aspiriant LLC first reported a position in Cencora in Q4 2023 and has held it in 5 quarters since.
  • Aspiriant LLC's Cencora position peaked at $264K in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Cencora as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.